Therefore, future studies will compare the therapeutic effects of different doses of MG combined with different injection times of anti-VEGF to determine the best therapeutic regimen and further explain the specific targets and mechanisms of MG in anti-inflammatory, anti-fibrosis, and its effects on the complement system. This evidence concerns the gene VEGFA and myasthenia gravis.